The requirements for free colon cancer screenings would be relaxed from this year to include people aged 45 to 49, as well as those aged 40 to 44 with a family history of the disease, the Health ...
A little-known mouse protein disrupts cancer-causing chemical changes to genes associated with human colorectal cancer cells and potentially could be used to treat solid tumors, according to a new ...
Biocytogen (HKEX: 02315), a global biotech company dedicated to discovering and developing novel antibody therapeutics, announced the licensing of its fully human antibodies to ...